Foundry Partners LLC Acquires 158,473 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Foundry Partners LLC increased its holdings in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 74.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 371,029 shares of the company's stock after buying an additional 158,473 shares during the period. Foundry Partners LLC owned 0.80% of Avanos Medical worth $8,322,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Kestrel Investment Management Corp bought a new position in Avanos Medical in the 4th quarter valued at $3,265,000. Charles Schwab Investment Management Inc. boosted its holdings in Avanos Medical by 6.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 570,442 shares of the company's stock valued at $11,534,000 after purchasing an additional 34,825 shares during the period. Public Employees Retirement System of Ohio boosted its holdings in Avanos Medical by 20.3% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 126,208 shares of the company's stock valued at $2,552,000 after purchasing an additional 21,255 shares during the period. SG Americas Securities LLC boosted its holdings in Avanos Medical by 391.1% in the 3rd quarter. SG Americas Securities LLC now owns 26,306 shares of the company's stock valued at $532,000 after purchasing an additional 20,949 shares during the period. Finally, Jupiter Asset Management Ltd. raised its position in shares of Avanos Medical by 234.2% during the 3rd quarter. Jupiter Asset Management Ltd. now owns 149,983 shares of the company's stock valued at $3,033,000 after buying an additional 105,100 shares in the last quarter. 95.17% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Separately, StockNews.com upgraded shares of Avanos Medical from a "hold" rating to a "buy" rating in a research report on Tuesday, March 19th.

Avanos Medical Price Performance

Shares of Avanos Medical stock traded up $0.01 on Friday, hitting $18.71. 183,669 shares of the company traded hands, compared to its average volume of 186,685. The firm's 50-day simple moving average is $19.31 and its 200 day simple moving average is $19.95. The company has a current ratio of 2.08, a quick ratio of 1.38 and a debt-to-equity ratio of 0.13. The company has a market cap of $864.40 million, a P/E ratio of -14.17, a P/E/G ratio of 1.09 and a beta of 0.96. Avanos Medical, Inc. has a 12-month low of $17.24 and a 12-month high of $31.31.

Avanos Medical (NYSE:AVNS - Get Free Report) last posted its quarterly earnings data on Tuesday, February 20th. The company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.01). The company had revenue of $173.30 million for the quarter, compared to analysts' expectations of $170.43 million. Avanos Medical had a negative net margin of 8.76% and a positive return on equity of 4.25%. The business's quarterly revenue was down 4.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.60 EPS. Analysts expect that Avanos Medical, Inc. will post 1.38 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Avanos Medical news, CFO Michael Greiner sold 8,000 shares of the business's stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $19.12, for a total value of $152,960.00. Following the completion of the sale, the chief financial officer now directly owns 151,495 shares of the company's stock, valued at $2,896,584.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.90% of the stock is currently owned by insiders.

Avanos Medical Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.